Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
- PMID: 34887571
- PMCID: PMC8656440
- DOI: 10.1038/s41569-021-00662-w
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
Erratum in
-
Author Correction: Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms.Nat Rev Cardiol. 2023 Aug;20(8):575. doi: 10.1038/s41569-023-00904-z. Nat Rev Cardiol. 2023. PMID: 37344581 Free PMC article. No abstract available.
Abstract
The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.
Conflict of interest statement
The authors declare no competing interests.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
